Charles Grosjean
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Charles Grosjean has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Abdelhadi Saoudi
Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III
1 shared publication - Anne Laurence Astier
MRC Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, United Kingdom
1 shared publication Aymeline Debonlier
INSERM U1291
1 shared publicationBeatrice Pignolet
INSERM U1291
1 shared publicationBeatriz Chaves
INSERM U1291
1 shared publication- Brittany Baker
Institut Pasteur, Université Paris Cité, Unit Evolutionary Biology of Microbial Cell, Paris, France
1 shared publication
Latest Publications
- Open Access
Archaeal cell envelopes selectively activate innate immunity through TLR2 in contrasts with multi-receptor bacterial sensing
The cell envelope of bacteria and fungi is a major source of microbial-associated molecular patterns (MAMPs), which are recognised by multiple host pattern recognition receptors (PRRs) such as TLRs and NODs. The key role of this recognition in protecting against infection and regulating diverse physiological processes has been studied for decades. In contrast, although the archaea are growingly recognised as an important component of the animal and human microbiome, their interaction with the innate immune system has been largely understudied. Here, we asked whether the archaeal cell envelope acts as MAMP. We selected 15 archaeal species from different environments, including the human microbiome, and harbouring diverse envelope characteristics, and we tested their ability to activate innate immune responses in human and murine immune cells. We first show that archaeal cells activate the innate immune transcription factor NF-kB and induce IL-6 secretion. Using whole archaeal cells, supernatants, and purified envelope components, we then find that none of the main PRR receptors which recognise the bacterial envelope (TLR4, TLR5, NOD1 and NOD2) are involved in this activation. We only detected activation of TLR2, regardless of the environmental origins of the archaea tested, although with overall lower activity compared to bacteria. We further demonstrate that different TLR2 heterodimers are involved, depending on the species, although the archaeal agonist remains unknown. Altogether, our results highlight a surprising paucity of interaction of archaeal cell envelope components with host PPRs, in contrast to bacteria, and open new avenues of research toward further investigation of archaea/host interplay.
Open AccessArchaeal cell envelopes selectively activate innate immunity through TLR2 in contrasts with multi-receptor bacterial sensing
The cell envelope of bacteria and fungi is a major source of microbial-associated molecular patterns (MAMPs), which are recognised by multiple host pattern recognition receptors (PRRs) such as TLRs and NODs. The key role of this recognition in protecting against infection and regulating diverse physiological processes has been studied for decades. In contrast, although the archaea are growingly recognised as an important component of the animal and human microbiome, their interaction with the innate immune system has been largely understudied. Here, we asked whether the archaeal cell envelope acts as MAMP. We selected 15 archaeal species from different environments, including the human microbiome, and harbouring diverse envelope characteristics, and we tested their ability to activate innate immune responses in human and murine immune cells. We first show that archaeal cells activate the innate immune transcription factor NF-kB and induce IL-6 secretion. Using whole archaeal cells, supernatants, and purified envelope components, we then find that none of the main PRR receptors which recognise the bacterial envelope (TLR4, TLR5, NOD1 and NOD2) are involved in this activation. We only detected activation of TLR2, regardless of the environmental origins of the archaea tested, although with overall lower activity compared to bacteria. We further demonstrate that different TLR2 heterodimers are involved, depending on the species, although the archaeal agonist remains unknown. Altogether, our results highlight a surprising paucity of interaction of archaeal cell envelope components with host PPRs, in contrast to bacteria, and open new avenues of research toward further investigation of archaea/host interplay.
- Open Access
- 26 February 2025
- Published by Springer Nature in Research Square
The multiple sclerosis associated CD226 risk variant alters vitamin D-induced human type I regulatory T cell differentiation by impairing LFA-1 activation
Multiple sclerosis (MS) is a complex inflammatory disease of the central nervous system (CNS), resulting from an intricate interplay between genetic predisposition and environmental factors. Vitamin D (VD) deficiency is one of the established risk factors for MS. CD46 costimulation of CD4+ T cells induces a switch from Th1 to type I regulatory cells (Tr1), characterized by increased IL-10 production. This switch is impaired in MS T cells but can be restored by VD, which also strongly promotes expression of CD226 on CD46-activated T cells. The rs763361 polymorphism in the CD226 gene, resulting in a non-synonymous Gly307Ser variant, is associated with increased risk for MS. Herein, we show that expression of this CD226 risk allele disrupts the ability of CD46-activated T cells to operate the IFNγ/IL-10 switch upon VD exposure. Mechanistically, the risk variant impairs activation of the integrin LFA-1, which sustains homotypic adhesion associated with acquisition of the Tr1 phenotype. LFA-1-mediated Tr1 differentiation is also impaired in MS T cells expressing the CD226 risk allele upon CD46 and VD stimulation. Our study unveils how, in the context of MS susceptibility, a genetic polymorphism and an environmental factor act in concert to control the differentiation of Tr1 cells.
- 26 February 2025
- Published by Springer Nature in Research Square
Open AccessThe multiple sclerosis associated CD226 risk variant alters vitamin D-induced human type I regulatory T cell differentiation by impairing LFA-1 activation
Multiple sclerosis (MS) is a complex inflammatory disease of the central nervous system (CNS), resulting from an intricate interplay between genetic predisposition and environmental factors. Vitamin D (VD) deficiency is one of the established risk factors for MS. CD46 costimulation of CD4+ T cells induces a switch from Th1 to type I regulatory cells (Tr1), characterized by increased IL-10 production. This switch is impaired in MS T cells but can be restored by VD, which also strongly promotes expression of CD226 on CD46-activated T cells. The rs763361 polymorphism in the CD226 gene, resulting in a non-synonymous Gly307Ser variant, is associated with increased risk for MS. Herein, we show that expression of this CD226 risk allele disrupts the ability of CD46-activated T cells to operate the IFNγ/IL-10 switch upon VD exposure. Mechanistically, the risk variant impairs activation of the integrin LFA-1, which sustains homotypic adhesion associated with acquisition of the Tr1 phenotype. LFA-1-mediated Tr1 differentiation is also impaired in MS T cells expressing the CD226 risk allele upon CD46 and VD stimulation. Our study unveils how, in the context of MS susceptibility, a genetic polymorphism and an environmental factor act in concert to control the differentiation of Tr1 cells.
- Open Access
- 1 January 1999
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 10846999,p. 147-152
A practical thermopneumatic valve
Previously, we reported a thermopneumatic silicone rubber membrane valve [1997]. This valve combined thermopneumatic actuation with a low modulus silicone rubber membrane. However, the leakage of the working fluid through the membrane rendered the valve unusable in a day or two. Here, we present extensive optimization and characterization of a redesigned valve structure. This new design has a suspended membrane heater optimized for low power consumption, a composite silicone rubber on Parylene membrane that exhibits low permeability and modulus, and a novel valve seat designed to improve sealing in the presence of particles. The valve has been extensively characterized with respect to power consumption vs. flow rate and transient response. Very low power consumption has been demonstrated. For example, less than 40 mW is required to switch a one slpm nitrogen flow at 33 psi. Water requires close to 100 mW due to the cooling effect of the liquid. The previously reported valve required more than 280 mW to switch a similar air flow.
- 1 January 1999
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 10846999,p. 147-152
Open AccessA practical thermopneumatic valve
Previously, we reported a thermopneumatic silicone rubber membrane valve [1997]. This valve combined thermopneumatic actuation with a low modulus silicone rubber membrane. However, the leakage of the working fluid through the membrane rendered the valve unusable in a day or two. Here, we present extensive optimization and characterization of a redesigned valve structure. This new design has a suspended membrane heater optimized for low power consumption, a composite silicone rubber on Parylene membrane that exhibits low permeability and modulus, and a novel valve seat designed to improve sealing in the presence of particles. The valve has been extensively characterized with respect to power consumption vs. flow rate and transient response. Very low power consumption has been demonstrated. For example, less than 40 mW is required to switch a one slpm nitrogen flow at 33 psi. Water requires close to 100 mW due to the cooling effect of the liquid. The previously reported valve required more than 280 mW to switch a similar air flow.